Board of Pharmacy Specialties (BPS) · BCPS Examination Specifications, effective September 2024; examination content outline created March 2023. On 2026-10-09, BPS's current table linked this outline for 2025 administrations onward and listed no future Pharmacotherapy replacement. The workbook's credential-based label, Board Certified Pharmacotherapy Specialist (BCPS) Examination, maps to this same BPS Pharmacotherapy specialty certification examination; the assigned slug is preserved.

This original 20-question sample covers selected topics across the outline. It does not reproduce official exam questions or cover every tested topic.

• Pharmacotherapy Specialty Certification
• Examination Content Outlines
• BCPS Examination Specifications — Effective September 2024
• 2026 BPS Updates to Pharmacist Certification and Recertification Processes
• SHEA/IDSA 2021 Focused Update for Clostridioides difficile Infection in Adults
• 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
• KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
• CKD Evaluation and Management — KDIGO
• GINA 2026 Summary Guide for Asthma Management and Prevention
• Surviving Sepsis Campaign Adult Guidelines — 2026
• ASH Diagnosis and Management of Heparin-Induced Thrombocytopenia
• Managing Acute Gastroenteritis Among Children: Oral Rehydration, Maintenance, and Nutritional Therapy
• Determining Drug Dosing in Adults with Chronic Kidney Disease
• The SHARE Approach: Shared Decisionmaking Tools and Training
• Medications at Transitions and Clinical Handoffs Toolkit for Medication Reconciliation
• Guide to Improving Patient Safety in Primary Care Settings — Teach-Back
• Revised Consensus Guideline for Therapeutic Monitoring of Vancomycin for Serious MRSA Infections
• VYBRIQUE (sildenafil) FDA Prescribing Information
• Pharmacy-Based Interventions to Improve Medication Adherence
• Talk About Costs: Tool 23
• CDC Grand Rounds: Improving Medication Adherence for Chronic Disease Management
• ISMP List of High-Alert Medications in Acute Care Settings
• ISMP Medication Safety Self Assessment for High-Alert Medications
• Guidelines for Vaccinating Pregnant Women
• Cochrane Handbook, Chapter 15: Interpreting Results and Drawing Conclusions
• CDC Field Epidemiology Manual: Analyzing and Interpreting Data
• Model for Improvement: Testing Changes
• Model for Improvement: Establishing Measures
• Cost-Effectiveness Analysis — CDC POLARIS
• IDSA 2019 Guideline for the Management of Asymptomatic Bacteriuria
• Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026 | SCCM